Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of DISHMAN PHARMA. For more details, see the DISHMAN PHARMA quarterly results and DISHMAN PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.9 |
No. of shares | m | 161.39 |
1 Week | % | 3.5 |
1 Month | % | -2.4 |
1 Year | % | 96.4 |
52 week H/L | Rs | 346.3/127.6 |
No. of Mths Year Ending |
12 Mar-12* |
12 Mar-13* |
12 Mar-14* |
12 Mar-15* |
12 Mar-16* |
5-Yr Chart Click to enlarge
|
---|
DISHMAN PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 107 | 122 | 107 | 183 | 374 | |
Low | Rs | 35 | 42 | 39 | 83 | 129 | |
Sales per share (Unadj.) | Rs | 138.6 | 157.0 | 171.0 | 196.0 | 197.0 | |
Earnings per share (Unadj.) | Rs | 7.0 | 12.4 | 13.5 | 14.8 | 21.2 | |
Diluted earnings per share | Rs | 3.5 | 6.2 | 6.8 | 7.4 | 10.6 | |
Cash flow per share (Unadj.) | Rs | 16.5 | 22.8 | 27.0 | 33.5 | 34.7 | |
Dividends per share (Unadj.) | Rs | 1.20 | 1.20 | 1.20 | 2.00 | 2.00 | |
Adj. dividends per share | Rs | 0.60 | 0.60 | 0.60 | 1.00 | 1.00 | |
Avg Dividend yield | % | 1.7 | 1.5 | 1.6 | 1.5 | 0.8 | |
Book value per share (Unadj.) | Rs | 115.1 | 127.7 | 145.9 | 153.4 | 179.9 | |
Adj. book value per share | Rs | 57.6 | 63.9 | 72.9 | 76.7 | 89.9 | |
Shares outstanding (eoy) | m | 80.70 | 80.70 | 80.70 | 80.70 | 80.70 | |
Price / Sales ratio | x | 0.5 | 0.5 | 0.4 | 0.7 | 1.3 | |
Avg P/E ratio | x | 10.1 | 6.6 | 5.4 | 8.9 | 11.9 | |
P/CF ratio (eoy) | x | 4.3 | 3.6 | 2.7 | 4.0 | 7.3 | |
Price / Book Value ratio | x | 0.6 | 0.6 | 0.5 | 0.9 | 1.4 | |
Dividend payout | % | 17.1 | 9.7 | 8.9 | 13.5 | 9.4 | |
Avg Mkt Cap | Rs m | 5,729 | 6,617 | 5,903 | 10,692 | 20,307 | |
Total wages/salary | Rs m | 2,941 | 3,509 | 4,123 | 4,232 | 5,355 |
DISHMAN PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 11,183 | 12,666 | 13,798 | 15,815 | 15,898 | |
Other income | Rs m | 129 | 178 | 249 | 869 | 265 | |
Total revenues | Rs m | 11,313 | 12,845 | 14,048 | 16,684 | 16,163 | |
Gross profit | Rs m | 2,245 | 2,901 | 3,321 | 3,127 | 4,103 | |
Depreciation | Rs m | 765 | 838 | 1,086 | 1,507 | 1,091 | |
Interest | Rs m | 729 | 788 | 921 | 897 | 944 | |
Profit before tax | Rs m | 879 | 1,453 | 1,564 | 1,592 | 2,334 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 312 | 450 | 471 | 394 | 624 | |
Profit after tax | Rs m | 568 | 1,003 | 1,093 | 1,198 | 1,710 | |
Gross profit margin | % | 20.1 | 22.9 | 24.1 | 19.8 | 25.8 | |
Effective tax rate | % | 35.4 | 31.0 | 30.1 | 24.8 | 26.7 | |
Net profit margin | % | 5.1 | 7.9 | 7.9 | 7.6 | 10.8 |
DISHMAN PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 6,323 | 6,733 | 8,245 | 10,135 | 11,018 | |
Current liabilities | Rs m | 6,631 | 7,127 | 9,028 | 11,048 | 9,517 | |
Net working cap to sales | % | -2.8 | -3.1 | -5.7 | -5.8 | 9.4 | |
Current ratio | x | 1.0 | 0.9 | 0.9 | 0.9 | 1.2 | |
Inventory Days | Days | 57 | 43 | 58 | 49 | 57 | |
Debtors Days | Days | 610 | 210 | 381 | 5 | 3 | |
Net fixed assets | Rs m | 16,251 | 16,178 | 18,032 | 17,954 | 18,787 | |
Share capital | Rs m | 161 | 161 | 161 | 161 | 161 | |
"Free" reserves | Rs m | 9,127 | 10,147 | 11,611 | 12,217 | 14,354 | |
Net worth | Rs m | 9,288 | 10,308 | 11,772 | 12,378 | 14,516 | |
Long term debt | Rs m | 5,121 | 4,336 | 4,121 | 3,302 | 4,189 | |
Total assets | Rs m | 22,574 | 22,911 | 26,277 | 28,089 | 29,805 | |
Interest coverage | x | 2.2 | 2.8 | 2.7 | 2.8 | 3.5 | |
Debt to equity ratio | x | 0.6 | 0.4 | 0.4 | 0.3 | 0.3 | |
Sales to assets ratio | x | 0.5 | 0.6 | 0.5 | 0.6 | 0.5 | |
Return on assets | % | 5.7 | 7.8 | 7.7 | 7.5 | 8.9 | |
Return on equity | % | 6.1 | 9.7 | 9.3 | 9.7 | 11.8 | |
Return on capital | % | 11.2 | 15.3 | 15.6 | 15.9 | 17.5 | |
Exports to sales | % | 30.4 | 28.4 | 27.9 | 22.7 | 24.9 | |
Imports to sales | % | 6.5 | 4.6 | 6.3 | 5.5 | 3.7 | |
Exports (fob) | Rs m | 3,404 | 3,595 | 3,855 | 3,598 | 3,956 | |
Imports (cif) | Rs m | 728 | 581 | 865 | 870 | 594 | |
Fx inflow | Rs m | 3,974 | 4,210 | 3,966 | 4,576 | 4,952 | |
Fx outflow | Rs m | 905 | 695 | 954 | 974 | 697 | |
Net fx | Rs m | 3,069 | 3,515 | 3,011 | 3,601 | 4,255 |
DISHMAN PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,536 | 1,651 | 3,445 | 2,937 | 2,786 | |
From Investments | Rs m | -1,040 | -1,173 | -2,568 | -1,581 | -1,529 | |
From Financial Activity | Rs m | -680 | -501 | -741 | -1,420 | -941 | |
Net Cashflow | Rs m | -185 | -23 | 136 | -64 | 317 |
Share Holding
Shareholding as on Mar 2017
|
Company Information
|
CHM: Janmejay R Vyas | COMP SEC: Shrima G Dave | YEAR OF INC: 1983 | BSE CODE: 532526 | FV (Rs): 2 | DIV YIELD (%): 0.3 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare DISHMAN PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.